BFF Bank SpA
F:2BF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.885
11.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
BFF Bank SpA
BFF Bank SpA, founded as Banca Farmafactoring, has carved a unique niche in the European financial services landscape. Initially created to address the specific needs of the healthcare and public administration sectors, the bank specializes in providing credit management and financial services to suppliers in these industries. Over the years, BFF Bank expanded its footprints across numerous European markets, offering its expertise in managing and financing trade receivables, which is the core of its business model. This specialization has allowed BFF to become a prominent partner for organizations that require proactive and efficient credit management services to ensure smoother cash flows and financial stability.
The bank's revenue model thrives on these factoring services, where it purchases accounts receivable at a discount, providing immediate liquidity to its clients. This approach not only benefits healthcare providers and other public sector companies by improving their working capital but also generates consistent returns for BFF through the interest and fees charged on these financial transactions. Additionally, its strong focus on risk management and in-depth knowledge of European public sector dynamics allows BFF Bank to accurately assess the creditworthiness of its diverse client base, ensuring a robust performance. By streamlining the financial processes for its clients, BFF Bank positions itself as a vital cog in the financial efficiency of Europe's public administration and healthcare sectors.
BFF Bank SpA, founded as Banca Farmafactoring, has carved a unique niche in the European financial services landscape. Initially created to address the specific needs of the healthcare and public administration sectors, the bank specializes in providing credit management and financial services to suppliers in these industries. Over the years, BFF Bank expanded its footprints across numerous European markets, offering its expertise in managing and financing trade receivables, which is the core of its business model. This specialization has allowed BFF to become a prominent partner for organizations that require proactive and efficient credit management services to ensure smoother cash flows and financial stability.
The bank's revenue model thrives on these factoring services, where it purchases accounts receivable at a discount, providing immediate liquidity to its clients. This approach not only benefits healthcare providers and other public sector companies by improving their working capital but also generates consistent returns for BFF through the interest and fees charged on these financial transactions. Additionally, its strong focus on risk management and in-depth knowledge of European public sector dynamics allows BFF Bank to accurately assess the creditworthiness of its diverse client base, ensuring a robust performance. By streamlining the financial processes for its clients, BFF Bank positions itself as a vital cog in the financial efficiency of Europe's public administration and healthcare sectors.
Net Profit: Adjusted net profit was EUR 35 million, in line with targets, despite higher factoring rescheduling.
Factoring Growth: Factoring profit before tax rose 9% year-on-year, with a 5% increase in the loan book; Italy saw double-digit (10%+) loan growth.
Past Due Reduction: Stock of past due loans fell 5% from December, with a substantial portion now in cure periods expected to improve future figures.
Liquidity & Capital: Deposits stood at EUR 8.5 billion and the CET1 capital ratio reached 13.7%, above the target level.
Volume Records: Group loan book and volumes hit record highs for a first quarter; Italy and Poland led this growth.
Guidance Affirmed: Management confirmed full-year and 2026 guidance, citing strong momentum and pipeline.
Dividend Ban: Dividend policy remains unchanged, but payout is subject to the lifting of the Bank of Italy’s dividend ban.